ARC101-P1-101: A first-in-human phase 1 study of ARC101, a next generation T cell engager (TCE), in patients with advanced solid tumors.

Authors: Prachi Bhave, Meena Okera, Michelle Frances Morris, Manish Sharma, Kyriakos P. Papadopoulos, Stephanie Lheureux, Christian K. Kollmannsberger, Laura Martinez-Solano, Crysti Iarossi, Jonathan Aaron Meyer, Jennifer Teti, Michael R. W. Streit, Oladapo O. Yeku

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.tps2671

Source: Full article

---

Abstract

TPS2671